BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 951 filers reported holding BAXTER INTL INC in Q2 2014. The put-call ratio across all filers is 0.79 and the average weighting 0.4%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,509,600 | -17.2% | 40,000 | 0.0% | 0.72% | -14.4% |
| Q2 2023 | $1,822,400 | +12.3% | 40,000 | 0.0% | 0.84% | +7.5% |
| Q1 2023 | $1,622,400 | -20.4% | 40,000 | 0.0% | 0.78% | -20.2% |
| Q4 2022 | $2,038,800 | -5.3% | 40,000 | 0.0% | 0.97% | -17.6% |
| Q3 2022 | $2,154,000 | -16.2% | 40,000 | 0.0% | 1.18% | -11.3% |
| Q2 2022 | $2,569,000 | -17.2% | 40,000 | 0.0% | 1.33% | -6.3% |
| Q1 2022 | $3,102,000 | -9.7% | 40,000 | 0.0% | 1.42% | -4.2% |
| Q4 2021 | $3,434,000 | +6.7% | 40,000 | 0.0% | 1.48% | -1.6% |
| Q3 2021 | $3,217,000 | -0.1% | 40,000 | 0.0% | 1.51% | +1.5% |
| Q2 2021 | $3,220,000 | -4.6% | 40,000 | 0.0% | 1.48% | -8.6% |
| Q1 2021 | $3,374,000 | +5.1% | 40,000 | 0.0% | 1.62% | +0.5% |
| Q4 2020 | $3,210,000 | -0.2% | 40,000 | 0.0% | 1.62% | -8.2% |
| Q3 2020 | $3,217,000 | -6.6% | 40,000 | 0.0% | 1.76% | -11.7% |
| Q2 2020 | $3,444,000 | +6.0% | 40,000 | 0.0% | 1.99% | -8.1% |
| Q1 2020 | $3,248,000 | -2.9% | 40,000 | 0.0% | 2.17% | +21.9% |
| Q4 2019 | $3,345,000 | -4.4% | 40,000 | 0.0% | 1.78% | -10.2% |
| Q3 2019 | $3,499,000 | +6.8% | 40,000 | 0.0% | 1.98% | +5.7% |
| Q2 2019 | $3,276,000 | +0.7% | 40,000 | 0.0% | 1.87% | -2.9% |
| Q1 2019 | $3,252,000 | +23.5% | 40,000 | 0.0% | 1.93% | +8.4% |
| Q4 2018 | $2,633,000 | -14.6% | 40,000 | 0.0% | 1.78% | -2.0% |
| Q3 2018 | $3,084,000 | +4.4% | 40,000 | 0.0% | 1.82% | -4.4% |
| Q2 2018 | $2,954,000 | +13.5% | 40,000 | 0.0% | 1.90% | +12.3% |
| Q1 2018 | $2,602,000 | +0.6% | 40,000 | 0.0% | 1.69% | +2.5% |
| Q4 2017 | $2,586,000 | +3.0% | 40,000 | 0.0% | 1.65% | -4.8% |
| Q3 2017 | $2,510,000 | +3.6% | 40,000 | 0.0% | 1.73% | -0.6% |
| Q2 2017 | $2,422,000 | +16.8% | 40,000 | 0.0% | 1.74% | +13.4% |
| Q1 2017 | $2,074,000 | +16.9% | 40,000 | 0.0% | 1.54% | +11.6% |
| Q4 2016 | $1,774,000 | -6.8% | 40,000 | 0.0% | 1.38% | -9.3% |
| Q3 2016 | $1,904,000 | +5.3% | 40,000 | 0.0% | 1.52% | +4.3% |
| Q2 2016 | $1,809,000 | +10.1% | 40,000 | 0.0% | 1.46% | +5.0% |
| Q1 2016 | $1,643,000 | +7.7% | 40,000 | 0.0% | 1.39% | +7.9% |
| Q4 2015 | $1,526,000 | +16.1% | 40,000 | 0.0% | 1.29% | +10.4% |
| Q3 2015 | $1,314,000 | -53.0% | 40,000 | 0.0% | 1.16% | -50.0% |
| Q2 2015 | $2,797,000 | +2.1% | 40,000 | 0.0% | 2.33% | +3.8% |
| Q1 2015 | $2,740,000 | -6.5% | 40,000 | 0.0% | 2.24% | -5.6% |
| Q4 2014 | $2,932,000 | +2.1% | 40,000 | 0.0% | 2.38% | -2.1% |
| Q3 2014 | $2,871,000 | -0.7% | 40,000 | 0.0% | 2.43% | -1.3% |
| Q2 2014 | $2,892,000 | -1.7% | 40,000 | 0.0% | 2.46% | -5.3% |
| Q1 2014 | $2,943,000 | +5.8% | 40,000 | 0.0% | 2.60% | +7.5% |
| Q4 2013 | $2,782,000 | – | 40,000 | – | 2.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |